Pnc Financial Services Group, Inc. Aerie Pharmaceuticals Inc Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$12.0 - $16.13 $456 - $612	-38 Reduced 24.68%	116 $1,000
Q1 2020 May 08, 2020	SELL	$11.84 - $25.52 $592 - $1,276	-50 Reduced 24.51%	154 $2,000
Q4 2019 Feb 07, 2020	BUY	$17.72 - $25.1 $2,835 - $4,016	160 Added 363.64%	204 $4,000
Q3 2019 Nov 08, 2019	BUY	$18.41 - $28.0 $110 - $168	6 Added 15.79%	44 $0
Q1 2018 May 11, 2018	BUY	$51.15 - $61.0 $818 - $976	16 Added 72.73%	38 $0
Q4 2017 Feb 09, 2018	BUY	$50.85 - $65.1 $1,118 - $1,432	22	22 $0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.